The Role of The African Vaccine Regulatory Forum (AVAREF) in The Accelerated Clinical Evaluation of Ebola Vaccine Candidates During the Large West Africa Epidemic
Bartholomew D. Akanmori(World Health Organization Regional Office for Africa), Richard Mihigo(World Health Organization Regional Office for Africa), Tieble Traore(World Health Organization Regional Office for Africa), David Mukanga(Essential Research (United States)), Michael D. Ward(Institute of Medicinal Molecular Design), Ahmed Bellah
Cited by 18
Related Papers
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria
|The Lancet|1998|329
Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on <i>Plasmodium falciparum</i> -Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A
|The Journal of Immunology|2000|305
Absolute Levels and Ratios of Proinflammatory and Anti‐inflammatory Cytokine Production In Vitro Predict Clinical Immunity to<i>Plasmodium falciparum</i>Malaria
|The Journal of Infectious Diseases|2002|245
<i>Plasmodium falciparum</i> Variant Surface Antigen Expression Varies Between Isolates Causing Severe and Nonsevere Malaria and Is Modified by Acquired Immunity
|The Journal of Immunology|2002|211
The prevalence of anti-Toxoplasma gondii antibodies in Ghanaian sheep and goats
|Acta Tropica|2000|170